Published in Br J Cancer on October 01, 1999
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect (2004) 2.76
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ (2001) 2.56
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol (2004) 2.16
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer (2003) 1.90
Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol (2006) 1.61
Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ (2001) 1.53
Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol (2006) 1.24
An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme. Br J Cancer (2004) 1.21
Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer (2000) 1.14
Recent advances: Sexually transmitted infections. BMJ (2001) 1.10
Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med (2007) 1.09
Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J Clin Microbiol (2011) 1.09
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer (2004) 1.08
Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol (2009) 1.08
A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer (2000) 1.08
Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol (2007) 1.04
Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience (2015) 1.00
Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis (2010) 1.00
Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis (2010) 0.99
Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix. Indian J Med Res (2012) 0.98
Evaluation of adjunctive HPV testing by Hybrid Capture II in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy. BMC Infect Dis (2003) 0.95
Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women. BMC Cancer (2010) 0.92
Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol (2005) 0.90
Cancer of the Uterine Cervix. BMC Womens Health (2004) 0.83
Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer (2000) 0.83
Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis. Cancer Med (2013) 0.82
Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis (2012) 0.79
Extended duration of the detectable stage by adding HPV test in cervical cancer screening. Br J Cancer (2003) 0.77
Seroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria. Int J Womens Health (2014) 0.77
Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease. J Clin Microbiol (2004) 0.77
Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer (2002) 0.76
The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection. Eur J Microbiol Immunol (Bp) (2013) 0.76
High Frequency of Human Papillomavirus Genotype 16 Among Patients With Anogenital Warts. Jundishapur J Microbiol (2015) 0.75
HPV immunohistochemical testing and cervical dysplasia. Clujul Med (2016) 0.75
Hybrid capture 2 test results after an initial equivocal RLU/CO value are dependent on age. Am J Clin Pathol (2013) 0.75
Value of high-risk human papillomavirus 16 deoxyribonucleic acid testing with cytological entities in peri and postmenopausal women. J Cytol (2013) 0.75
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
Human papillomavirus testing in primary cervical screening. Lancet (1995) 5.09
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
Does mild atypia on a cervical smear warrant further investigation? Lancet (1986) 3.36
Mild cervical dyskaryosis: safety of cytological surveillance. Lancet (1992) 3.09
Should patients with mild atypia in a cervical smear be referred for colposcopy? Br J Obstet Gynaecol (1986) 2.40
Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer (1994) 2.35
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol (1998) 2.05
Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer (1997) 2.00
Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol (1995) 1.21
An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol (1995) 1.14
Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol (1996) 1.05
Semiautomated detection of human papillomavirus DNA of high and low oncogenic potential in cervical smears. Clin Chem (1994) 0.95
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39
Human papillomavirus testing in primary cervical screening. Lancet (1995) 5.09
Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med (1997) 4.08
HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA (2000) 3.93
Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem (1997) 3.67
Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]. Lancet (1992) 3.48
Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem (1995) 3.17
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J Biol Chem (1995) 2.91
Regulation of cell size in the yeast Saccharomyces cerevisiae. J Bacteriol (1979) 2.90
Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (1995) 2.50
Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis (1988) 2.47
Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet (1996) 2.47
Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer (1994) 2.35
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J Virol (1987) 2.29
Glucose utilization in vivo by human pulmonary neoplasms. Cancer (1987) 2.29
"Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol (1997) 2.25
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med (1999) 2.17
Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ (2000) 2.12
Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J (1997) 2.10
Receptor activity of rotavirus nonstructural glycoprotein NS28. J Virol (1989) 2.09
Tuberculin sensitivity testing and treatment of latent tuberculosis remains effective for tuberculosis control in human immunodeficiency virus-infected patients in Hong Kong. Hong Kong Med J (2013) 2.02
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res (1993) 1.97
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol (2001) 1.93
In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med (1994) 1.88
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res (1990) 1.81
Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A (1986) 1.80
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80
Fast diffusion along defects and corrugations in phospholipid P beta, liquid crystals. Biophys J (1983) 1.78
Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer (2013) 1.68
A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology (1985) 1.67
Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med (2000) 1.67
Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis (1999) 1.64
The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun (1993) 1.63
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst (2000) 1.62
Characterization of a DNA repair domain containing the dihydrofolate reductase gene in Chinese hamster ovary cells. J Biol Chem (1986) 1.51
Reliability of colposcopy and directed punch biopsy. Br J Obstet Gynaecol (1990) 1.51
Defects in ZnO nanorods prepared by a hydrothermal method. J Phys Chem B (2006) 1.51
A multicenter trial of photorefractive keratectomy for residual myopia after previous ocular surgery. Summit Therapeutic Refractive Study Group. Ophthalmology (1995) 1.50
Spitz nevus versus spitzoid melanoma: diagnostic difficulties, conceptual controversies. Adv Anat Pathol (2006) 1.50
Identification of potential CSF biomarkers in ALS. Neurology (2006) 1.50
Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol (2001) 1.49
DNA adducts in different tissues of smokers and non-smokers. Int J Cancer (1990) 1.48
Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain. Hum Pathol (1999) 1.46
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol (1987) 1.42
Laser vaporization versus laser excision conization in the treatment of cervical intraepithelial neoplasia. Obstet Gynecol (1989) 1.41
Two glycoproteins are produced from the rotavirus neutralization gene. Virology (1986) 1.41
Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis. Hong Kong Med J (2013) 1.39
A review of anaesthesia in ophthalmology. Singapore Med J (1993) 1.39
Atypical stromal cells in a hyperplastic endometrial polyp. Histopathology (1995) 1.38
Solid and papillary epithelial neoplasm arising in heterotopic pancreatic tissue of the mesocolon. J Clin Pathol (2001) 1.37
Beta and gamma frequency synchronization by dendritic gabaergic synapses and gap junctions in a network of cortical interneurons. J Neurosci (2001) 1.36
Formation of endothelin by cultured airway epithelial cells. FEBS Lett (1989) 1.34
Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol (1999) 1.31
Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J Invest Dermatol (1997) 1.29
Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian follicles in long-term culture. Hum Reprod (1997) 1.29
Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology (2004) 1.29
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer (1995) 1.25
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol (1999) 1.24
Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). Hum Mol Genet (1997) 1.24
Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants. Hum Reprod (1996) 1.24
Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation (1987) 1.23
Inferior temporal neurons show greater sensitivity to nonaccidental than to metric shape differences. J Cogn Neurosci (2001) 1.22
Pulmonary fibrosis correlates with duration of tissue neutrophil activation. Am J Respir Crit Care Med (1998) 1.22
Heterogeneous expression of protein and mRNA in pyruvate dehydrogenase deficiency. Proc Natl Acad Sci U S A (1988) 1.22
Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet (1998) 1.20
Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet (1998) 1.20
Deficiency of coenzyme Q 10 in human heart disease. II. Int J Vitam Nutr Res (1972) 1.19
Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol (1995) 1.19
Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy (1994) 1.19
Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ (2012) 1.19
Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer (2010) 1.18
Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Int J Cancer (1989) 1.16
Activation of thiol esters. Partial synthesis of cytochalasins A and B. J Am Chem Soc (1977) 1.15
Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer (2000) 1.14
Semi-quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality. Br J Obstet Gynaecol (1994) 1.14
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis (2001) 1.14
Molecular analysis of the role of streptococcal pyrogenic Exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol Microbiol (1999) 1.14
A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol (1993) 1.13
A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation (1992) 1.13